Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours Β· Estimated delivery Oct 28 - Nov 2
In vitro models of Parkinsons disease The discovery and development of novel PD therapeutics strongly rely on the presence of robust in vitro models
The goal is sustainable, healthy weight loss, and that often happens gradually
SURMOUNT-1 trial showing 15-21% weight loss
Investigating the impact of selected B vitamins (B1, B2, B6, and B12) on acute colitis induced experimentally in rats
Given that obesity is a chronic and relapsing disease, it is important to understand the effectiveness of different strategies to maintain WL: TRIUMPH-6 (NCT06859268) will assess changes in bodyweight at 116 weeks in individuals with obesity who have completed 80 weeks of retatrutide, comparing continued treatment at high or low doses of retatrutide versus switching to placebo for the last 36 weeks
US$ 26.49
US$ 28.01
US$ 20.51
US$ 28.22
US$ 25.68
US$ 23.24
US$ 23.98
US$ 26.13
